Global Circulating Tumor Cells Market
This report studies the Circulating Tumor Cells market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Circulating Tumor Cells market by product and Application/end industries.
In 2017, the global circulating tumor cells market size was 731.47 million US$ and it is expected to reach 3231.85 million US$ by the end of 2025, with a CAGR of 20.66% during 2019-2025.
Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3267428-global-circulating-tumor-cells-market-size-status-and-forecast-2025
This report focuses on the global top players, covered
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of circulating tumor cells in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
APEC
On the basis of product, the circulating tumor cells market is primarily split into
CTC Enrichment
CTC Detection
CTC Analysis
On the basis on the end users/applications, this report covers
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Other
Table of Contents-Key Points Covered
1 Industry Overview 1
1.1 Circulating Tumor Cells Market Overview 1
1.1.1 Circulating Tumor Cells Product Scope 1
1.1.2 Market Status and Outlook 2
1.2 Global Circulating Tumor Cells Market Size and Analysis by Regions (2013-2018) 2
1.2.1 United States Circulating Tumor Cells Market Status and Outlook 4
1.2.2 Europe Circulating Tumor Cells Market Status and Outlook 5
1.2.3 Japan Circulating Tumor Cells Market Status and Outlook 6
1.2.4 China Circulating Tumor Cells Market Status and Outlook 7
1.2.5 RoA Circulating Tumor Cells Market Status and Outlook 8
1.2.6 RoW Circulating Tumor Cells Market Status and Outlook 9
1.3 Classification of Circulating Tumor Cells by Product 9
1.3.1 Global Circulating Tumor Cells Revenue (Million USD) and Growth Comparison by Product (2013-2025) 9
1.3.2 Global Circulating Tumor Cells Revenue (Million USD) Market Share by Product in 2017 11
1.3.3 CTC Enrichment 12
1.3.4 CTC Detection 13
1.3.5 CTC Analysis 13
1.4 Circulating Tumor Cells Market by End Users/Application 14
1.4.1 Breast Cancer Diagnosis and Treatment 15
1.4.2 Prostate Cancer Diagnosis and Treatment 16
1.4.3 Colorectal Cancer Diagnosis and Treatment 17
1.4.4 Lung Cancer Diagnosis and Treatment 18
1.5 Macroscopic Indicator 20
1.5.1 GDP for Major Regions 20
1.5.2 Population and Labor Considered for Forecast 22
1.5.3 Disposable Income Considered for Forecast 24
2 Global Circulating Tumor Cells Competition Analysis by Players 26
2.1 Global Circulating Tumor Cells Market Size (Million USD) by Players (2017-2018) 26
2.2 Competitive Status 30
3 Company (Top Players) Profiles and Key Data 31
3.1 Menarini-Silicon Biosystems 31
3.1.1 Company Basic Information, Key Products and Sales Area 31
3.1.2 Circulating Tumor Cells Product Overview 32
3.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 33
3.2 Qiagen (Adnagen) 33
3.2.1 Company Basic Information, Key Products and Sales Area 33
3.2.2 Circulating Tumor Cells Product Information 34
3.2.3 Qiagen (Adnagen) Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 35
3.3 Advanced Cell Diagnostics 35
3.3.1 Company Basic Information, Key Products and Sales Area 35
3.3.2 Circulating Tumor Cells Product Overview 36
3.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 36
3.4 ApoCell 37
3.4.1 Company Basic Information, Key Products and Sales Area 37
3.4.2 Circulating Tumor Cells Product Overview 38
3.4.3 ApoCell Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 38
3.5 Epic Sciences 39
3.5.1 Company Basic Information, Key Products and Sales Area 39
3.5.2 Circulating Tumor Cells Product Overview 40
3.5.3 Epic Sciences Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 40
3.6 Greiner Bio-one GmbH 41
3.6.1 Company Basic Information, Key Products and Sales Area 41
3.6.2 Circulating Tumor Cells Product Overview 42
3.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 43
3.7 Cynvenio 43
3.7.1 Company Basic Information, Key Products and Sales Area 43
3.7.2 Circulating Tumor Cells Product Overview 44
3.7.3 Cynvenio Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 44
3.8 SurExamBio-Tech 45
3.8.1 Company Basic Information, Key Products and Sales Area 45
3.8.2 Circulating Tumor Cells Product Overview 46
3.8.3 SurExamBio-Tech Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 47
3.9 Fluxion Biosciences 47
3.9.1 Company Basic Information, Key Products and Sales Area 47
3.9.2 Circulating Tumor Cells Product Overview 48
3.9.3 Fluxion Biosciences Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 49
3.10 Ikonisys 50
Continued….
Complete Report Details @ https://www.wiseguyreports.com/reports/3267428-global-circulating-tumor-cells-market-size-status-and-forecast-2025
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com